Nefiracetam 200mg Capsules
Nefiracetam 200mg Capsules contain a precisely calibrated structural mass of 200mg of N-(2,6-dimethylphenyl)-2-(2-oxopyrrolidin-1-yl)acetamide, an advanced hydrophobic pyrrolidone derivative belonging to the racetam family of chemical agents. Originally developed as a lipophilic analogue of piracetam, nefiracetam features a distinct di-methylated phenyl ring system attached to its acetamide side chain. Formulated within standardized, premium solid capsules under strict industrial quality controls, these 200mg reference units are engineered exclusively for in vitro laboratory analysis, forensic toxicology screening, and comparative neuropharmacological binding assays.
Sourcing this pyrrolidone core in a pre-measured 200mg capsule format provides critical handling and precision advantages for analytical research networks. The protective shell completely eliminates the measurement tolerances, fine powder containment hazards, and micro-weighing calibration variances frequently encountered when manipulating raw uncompressed racetam powders.
The Advantages of Standardized 200mg Capsule Formats
Utilizing Nefiracetam 200mg Capsules rather than loose bulk powder introduces essential operational controls that safeguard data precision and protect the structural integrity of your chemical repository.
1. Mitigation of Aerosolization and Cross-Contamination Risks
Raw racetam powders are inherently prone to localized static clinging and aerosolization during material transfers. Unintentional airborne dust migration represents a major vector for laboratory cross-contamination and accidental technician exposure. The enclosed capsule design completely secures the crystalline matrix, allowing laboratory personnel to handle, transfer, and isolate the exact active mass with complete volumetric safety.
2. High Unit Homogeneity and Thermodynamic Protection
Hydrophobic pyrrolidone derivatives require stable environmental baselines to prevent atmospheric moisture clumping or crystalline degradation over extended research intervals. The capsule barrier minimizes the active surface area exposed to ambient humidity and environmental factors. Combined with uniform industrial blending, each individual capsule delivers an exact, unvarying 200mg chemical payload ($\pm 0.5\%$), protecting longitudinal assays from baseline drift.
The Structural Science of Nefiracetam
The molecular framework of Nefiracetam serves as a vital point of comparison within modern cognitive research and structural activity relationship ($SAR$) models. According to technical data archived in the National Center for Biotechnology Information (NCBI) PubChem Database, the addition of a 2,6-dimethylphenyl group to the acetamide backbone fundamentally alters its lipophilicity and broadens its receptor binding profile compared to baseline racetams.
1. Phenyl-Ring Methylation and Lipophilic Dynamics
The pharmacodynamics of nefiracetam are strictly dictated by its unique chemical architecture:
-
Hydrophobic Modification: The presence of the aromatic ring substituted with two methyl groups ($-\text{CH}_3$) at the 2 and 6 positions significantly enhances the molecule’s lipid solubility profile, allowing it to interface differently with cellular lipid bilayers than hydrophilic analogs.
-
Multi-Channel Agonism Profiles: In vitro functional assays confirm that nefiracetam interacts uniquely with central neurotransmitter fields. It prolongs the opening of L-type and T-type voltage-gated calcium ($Ca^{2+}$) channels and acts as a potent positive allosteric modulator of both alpha-7 nicotinic acetylcholine ($nACh$) receptors and specific $NMDA$ receptor complexes.
2. Streamlined Solution Kinetics and Reconstitution
The crystalline powder enclosed within the protective shell is optimized for rapid, predictable dissociation when introduced to appropriate analytical carrier fluids:
-
Solvent Compatibility: Due to its hydrophobic nature, nefiracetam dissolves efficiently in organic matrices such as high-purity laboratory methanol, anhydrous ethanol, and dimethyl sulfoxide ($DMSO$), as well as displaying acceptable solubility in slightly warm aqueous saline buffers.
-
Simplified Molar Calculations: Because each solid capsule provides a validated 200mg chemical baseline standard, research facilities can skip initial micro-gram powder weighing steps, minimizing processing times and eliminating weighing-scale discrepancies.
Technical Specifications: Nefiracetam 200mg Assay
To preserve objective analytical standards for seamless laboratory integration, all promotional language is omitted in favor of verified empirical chemical values.
| Parameter | Detailed Empirical Specification |
| Chemical Identification | N-(2,6-dimethylphenyl)-2-(2-oxopyrrolidin-1-yl)acetamide |
| Common Designations | Nefiracetam / DM-9301 |
| Substance Classification | Pyrrolidone Derivatives / Racetam Structural Analogs |
| CAS Registry Number | 77191-36-7 |
| Systemic Purity Level | ≥99.0% Active Compound Purity verified via HPLC / GC-MS |
| Molecular Formula | $C_{14}H_{18}N_{2}O_{2}$ |
| Exact Formula Weight | 246.31 g/mol |
| Unit Calibration | Exactly 200mg of active ingredient per capsule standard |
Frequently Asked Questions Regarding Laboratory Compliance
What are the primary solubility limits of this compound?
Nefiracetam displays high lipophilicity compared to traditional racetams. It dissolves optimally in polar organic solvents like methanol, anhydrous laboratory ethanol, and acetone, making it highly adaptable for automated liquid chromatography-mass spectrometry (LC-MS) mapping.
How should this chemical material be stored to protect structural stability?
To maximize stability and prevent moisture absorption, store the capsules in their original tightly sealed container within a cool, dry environment shielded from direct UV exposure. Controlled room temperatures between 15°C and 25°C are adequate for standard projects; however, for multi-year archival storage, keeping the sealed material under desiccated conditions is highly recommended to completely halt trace molecular breakdown. For comprehensive safety protocols and international handling guidelines, researchers can consult documentation provided by the European Chemicals Agency (ECHA).
Is this chemical compound approved for human consumption or clinical distribution?
No. This material is synthesized, refined, and encapsulated strictly for in vitro laboratory analysis, forensic identification, and scientific research. It is an unapproved novel compound within this framework and is explicitly prohibited from human consumption, veterinary use, or any form of in vivo clinical testing.
Secure Industrial Chemical Excellence
Do not compromise your laboratory’s analytical data or ongoing research cycles on unverified, loosely handled chemical products that exhibit heavy localized degradation. By selecting our Nefiracetam 200mg Capsules, you introduce uncompromising laboratory purity, verifiable chemical stability, and immaculate baseline precision into your experimental workflow. The resulting mitigation of trace impurities, highly predictable solubility profiles, and clear assay metrics will empower your research collective to break through analytical plateaus with absolute, unwavering confidence.
